Jill DeSimone
CIK: 0001930479
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Praxis Precision Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct837 shares at avg. $315.70$264K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Exercise(M)Direct8.6K shares at avg. $44.25$379K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Exercise(M)Direct3K shares at avg. $147.30$447K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct10 shares at avg. $301.44$3K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct120 shares at avg. $303.13$36K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct320 shares at avg. $305.31$98K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct683 shares at avg. $306.77$210K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct1.2K shares at avg. $308.24$382K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct999 shares at avg. $309.38$309K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct1.8K shares at avg. $310.89$544K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct2.9K shares at avg. $311.91$890K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct1K shares at avg. $312.83$314K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct504 shares at avg. $313.66$158K - Jun 24, 2026PRAX
Praxis Precision Medicines, Inc.
Sale(S)Direct1.3K shares at avg. $314.90$403K - Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
Award(A)Direct1.4K shares- - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
Award(A)DirectStock Option (Right to Buy)
10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 837 | $315.70 | $264,245 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Exercise(M) | 8,566 | $44.25 | $379,046 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Exercise(M) | 3,034 | $147.30 | $446,908 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 10 | $301.44 | $3,014 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 120 | $303.13 | $36,375 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 320 | $305.31 | $97,699 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 683 | $306.77 | $209,522 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 1,240 | $308.24 | $382,221 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 999 | $309.38 | $309,074 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 1,750 | $310.89 | $544,056 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 2,854 | $311.91 | $890,203 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 1,004 | $312.83 | $314,081 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 504 | $313.66 | $158,086 | Direct |
| Jun 24, 2026 | PRAX Praxis Precision Medicines, Inc. | Sale(S) | 1,279 | $314.90 | $402,758 | Direct |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc. | Award(A) | 1,371 | - | $0 | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award(A) Stock Option (Right to Buy) | 10,520 | - | - | Direct |
1-16 of 16 transactions
About DeSimone Jill
DeSimone Jill (SEC CIK 0001930479) files insider reports with the SEC as Director of Praxis Precision Medicines, Inc. (PRAX).
Signal8 holds 3 ownership filings by DeSimone Jill, all Form 4s, filed between Jun 27, 2025 and Jun 26, 2026. Those filings report 16 transactions, from Jun 26, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DeSimone Jill's filings is in BOSTON, MA.
Recent filings by DeSimone Jill
- Jun 24, 2026: Open-market sale of PRAX shares (Form 4, code S).
- Jun 24, 2026: Option exercises of PRAX shares (2 lines, Form 4, code M).
- Jun 24, 2026: Open-market sales of PRAX shares (11 lines, Form 4, code S).
- Jun 10, 2026: Grant or award of PRAX shares (Form 4, code A).
- Jun 26, 2025: Grant or award of PRAX derivative securities (Form 4, code A).
Other insiders filing for Praxis Precision Medicines, Inc. (PRAX)
- Souza Marcio, Chief Executive Officer
- Arbuckle Stuart A, Director
- Chodakewitz Jeffrey, Director
- YOUNG WILLIAM D, Director
- Cudkowicz Merit Ester, Director
- MITCHELL DEAN J, Director